Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 51079-923

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 51079-923). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa And Levodopa Er 25 mg/100 mg Tablets Unit Carton Label (Image 01)

Label for Carbidopa and Levodopa Extended-Release Tablets USP, 50 mg carbidopa / 200 mg levodopa, oral dosage form. The label shows an oval tablet imprinted with "9 14" and indicates a package containing 100 tablets (10 x 10). Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV.*

FDA Label Image

Carbidopa And Levodopa Er 50 mg/200 mg Tablets Unit Carton Label (Image 02)

Packaging label for Carbidopa and Levodopa extended-release tablets by Mylan Institutional Inc. The blue unit-dose package includes warnings about non-child resistance, institutional use only, and drug safety precautions. The label features the Mylan logo and space to view the lot number and expiration date through a window.*

FDA Label Image

Unit Carton (Image 03)

Chemical structure of carbidopa, represented as a molecular diagram showing its atoms and bonds, including a water molecule (H2O) associated as a hydrate.*

FDA Label Image

Unit Carton (Image 04)

Chemical structure of carbidopa, one of the active ingredients in Carbidopa and Levodopa extended-release tablets. The diagram shows the molecular arrangement including hydroxyl groups, an amine group, and a carboxylic acid group.*

FDA Label Image

Image 05

Carbidopa and Levodopa Extended-Release Tablets, USP 25 mg/100 mg oral tablets by Mylan Institutional Inc. The label shows the NDC 51079-978-20 and depicts a gray, oval tablet imprinted with '88'. The package contains 100 tablets (10 x 10). Storage instructions and prescription-only status are also visible.*

FDA Label Image

Image 06

Unit-dose packaging label for Carbidopa and Levodopa extended-release tablets by Mylan Institutional Inc. The label includes safety and usage instructions noting that the package is not child resistant and for institutional use only. It also states the container provides light resistance and directs users to a window for the lot number and expiration date. The Mylan logo and distributor information are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.